Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Eger

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Journal of the American Chemical Society|December 8, 2011
Protein conformational gating of enzymatic activity in xanthine oxidoreductaseHiroshi Ishikita, Bryan T Eger, Ken Okamoto, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinolKen Okamoto, Bryan T Eger, Tomoko Nishino, et al.
The FEBS Journal|June 3, 2008
Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidaseTomoko Nishino, Ken Okamoto, Bryan T Eger, et al.
Clinical Oral Investigations|May 10, 2000
Absence of an especially toxic clone among isolates of Actinobacillus actinomycetemcomitans recovered from army recruitsA Macheleidt, H P Müller, T Eger, et al.
Occupational Medicine (Oxford, England)|January 4, 2011
Vasospasm in the feet in workers assessed for HAVSR House, D Jiang, A Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibitionKen Okamoto, Koji Matsumoto, Russ Hille, et al.
The Journal of Biological Chemistry|November 8, 2002
An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibitionKen Okamoto, Bryan T Eger, Tomoko Nishino, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversionC Enroth, B T Eger, K Okamoto, et al.
Clinical Oral Investigations|January 18, 2020
Long-term effects of splint therapy in patients with posttraumatic stress disease (PTSD)A Wolowski, T Eger, R Braas, et al.
Journal of Biomechanics|December 14, 2019
Development of a two-dimensional dynamic model of the foot-ankle system exposed to vibrationD Chadefaux, K Goggins, C Cazzaniga, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Journal of the American Chemical Society|December 8, 2011
Protein conformational gating of enzymatic activity in xanthine oxidoreductaseHiroshi Ishikita, Bryan T Eger, Ken Okamoto, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinolKen Okamoto, Bryan T Eger, Tomoko Nishino, et al.
The FEBS Journal|June 3, 2008
Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidaseTomoko Nishino, Ken Okamoto, Bryan T Eger, et al.
Clinical Oral Investigations|May 10, 2000
Absence of an especially toxic clone among isolates of Actinobacillus actinomycetemcomitans recovered from army recruitsA Macheleidt, H P Müller, T Eger, et al.
Occupational Medicine (Oxford, England)|January 4, 2011
Vasospasm in the feet in workers assessed for HAVSR House, D Jiang, A Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibitionKen Okamoto, Koji Matsumoto, Russ Hille, et al.
The Journal of Biological Chemistry|November 8, 2002
An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibitionKen Okamoto, Bryan T Eger, Tomoko Nishino, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversionC Enroth, B T Eger, K Okamoto, et al.
Clinical Oral Investigations|January 18, 2020
Long-term effects of splint therapy in patients with posttraumatic stress disease (PTSD)A Wolowski, T Eger, R Braas, et al.
Journal of Biomechanics|December 14, 2019
Development of a two-dimensional dynamic model of the foot-ankle system exposed to vibrationD Chadefaux, K Goggins, C Cazzaniga, et al.
Pageof 6